Latest news & press RSS feed

nanoTherics moves into Keele University Science and Business Park to support growth plans

nanoTherics, a Keele University spin out, has set up base at Keele University Science and Business Park (KUSBP) and is making its’ mark on the biomedical industry.

(more…)

Next Page »

nanoTherics Launches magnefect DUO Transfection Devices – New, Flexible Oscillating Magnet-Based Systems Enabling Improved Efficiencies and up to 192 Parallel Transfections

nanoTherics, a UK-based scientific medical research devices company, is pleased to announce launch of the magnefect-nano II DUO and the magnefect-LT DUO transfection systems which enable up to 192 transfection experiments to be performed in parallel.

(more…)

Next Page »

nanoTherics launch magnefect-nano II

nanoTherics Launches the magnefect-nano II™ – A New, Compact, Oscillating Magnet-Based System That Improves Transfection Efficiencies and Cell Viabilities
(more…)

Next Page »

nanoTherics launch the magnetherm™ – The only commercially available hyperthermia device with frequency selection

nanoTherics, a scientific medical research devices company founded in 2007, is pleased to announce launch of the magnetherm™, a new device designed to measure thermal effects of magnetic nanoparticles for hyperthermia applications. The system is totally unique and is the only commercially available hyperthermia device available for measuring these thermal effects that includes flexibility in frequency selection. (more…)

Next Page »

nanoTherics launch magnefect-LT

nanoTherics Launches the magnefect-LT™. Our new, low priced oscillating magnet-based system that improves transfection efficiencies and cell viabilities.

Next Page »

Catapult and Mercia invest in Staffordshire-based nanoTherics

Catapult Venture Managers and Mercia Technology Seed Fund are key investors in a £1.1m funding round into Staffordshire-based nanoTherics, a company at the cutting edge of research into the growing gene therapy replacement market. (more…)

Next Page »

nanotherics and Nanobiomagnetics enter global magnetic nanoparticle cross-license agreement for bio applications

Officials at UK-based nanoTherics Limited and US-based NanoBioMagnetics Inc, announced today that they have entered into a global cross-license agreement that provides their respective organisations with access to new business opportunities outside their respective geographies. (more…)

Next Page »

nanoTherics Launches the magnefect-nano™ – The System for Improved Gene Transfection

nanoTherics, a scientific medical research devices company founded in 2007, is pleased to announce launch of the magnefect-nano™, a new device for improved gene transfection. The system uses a unique technique applying proprietary magnet configurations and oscillating array systems to promote particle/DNA uptake into cells thus significantly improving non-viral gene transfection whilst maintaining cell viability.

(more…)

Next Page »

nanoTherics Wins Research & Development Grant from Advantage West Midlands to Further Augment Gene Transfection Product Portfolio

nanoTherics, a scientific medical research devices company founded in 2007 following on from cutting-edge biomedical research conducted at Keele University and the University of Florida, is delighted to announce it has been awarded a Research & Development (R&D) Grant from the regional development agency Advantage West Midlands (AWM). (more…)

Next Page »

nanoTherics Wins “Impact Through Innovation” Lord Stafford Award

nanoTherics, a scientific medical research devices company founded in 2007 following on from cutting-edge biomedical research conducted at Keele University and the University of Florida, is pleased to announce it has won the “Impact Through Innovation” Lord Stafford Award for the commercial exploitation of a novel gene transfection technology. (more…)

Next Page »